Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-CA-04
Country
CA
Application Type
National Stage
Patent Status
Issued
Patent Number
Publication Number
Application Number
2934075
IC
NCI
Date Filed
Date Issued
Patent PDF